Skip to Content

Press Releases

Date Title and Summary Additional Formats
Toggle Summary Stanford Researchers Use Single-Cell Mass Cytometry to Predict Recovery Time from Surgery
Fluidigm's CyTOF® Mass Cytometry Instrument Unlocks Responses in Immune Cell Subsets
View HTML
Toggle Summary Fluidigm’s New JunoTM System Shatters Barriers For SNP Genotyping
New System Provides Simple Workflow, Requires Minimal Amount of Sample Input and Hand
View HTML
Toggle Summary UCSF/Fluidigm Paper Proves Shallow Sequencing of Related Single Cells Sufficient to Harvest Meaningful Biological Information
New Method   Decreases the Cost of Single-Cell Sequencing; Frees Up Resources to Analyze More Cells SOUTH SAN FRANCISCO, Calif.--( BUSINESS WIRE )--In a paper published in  Nature Biotechnology  this week, UC San Francisco and Fluidigm Corporation (NASDAQ:FLDM) scientists have demonstrated that
View HTML
Toggle Summary Fluidigm Announces Early Access Program for New Imaging Mass Cytometry Platform
SOUTH SAN FRANCISCO, Calif., July 31, 2014 - Fluidigm Corporation (NASDAQ:FLDM) has begun accepting applications to an early access program for its upcoming imaging mass cytometry platform. Prototypes of the product are expected to begin shipping to early access partners by the end of this year.
View HTML
Toggle Summary Fluidigm Reports Q2 2014 Results
Strong Q2 2014 organic revenue growth of 32% year-over-year
View HTML
Toggle Summary Fluidigm to Announce Q2 2014 Financial Results and Host Conference Call for Investors
SOUTH SAN FRANCISCO, Calif., July 23, 2014 — Fluidigm Corporation (NASDAQ:FLDM) will report its second quarter 2014 financial results on July 31, 2014, after close of market.   Gajus Worthington, Fluidigm president and chief executive officer, and Vikram Jog, chief financial officer, will host a
View HTML
Toggle Summary Single-Cell mRNA Sequencing Helps Reveal the Role of “Precocious” Dendritic Cells in Inflammatory Response
Study Demonstrates the Importance of Single-Cell Sequencing to Identify Rare Cell...
View HTML
Toggle Summary Fluidigm Accelerates Single-Cell Science with the New C1™ Open App™ Program
Program enables researchers to develop new single-cell applications on the C1&#8482 Single-Cell Auto Prep
View HTML
Toggle Summary Fluidigm Ships FLEXsixTM Integrated Fluidic Circuits to Genotyping and Gene Expression Customers
Fluidigm Ships Flex six™ Integrated Fluidic Circuits to Genotyping and Gene Expression Customers   SOUTH SAN FRANCISCO, Calif., June 3, 2014 — Fluidigm Corporation (NASDAQ:FLDM) has begun shipping production volumes of its Flex Six™ integrated fluidic circuits (IFCs) to genotyping and gene
View HTML
Toggle Summary Fluidigm to Present at the Bank of America Merrill Lynch 2014 Healthcare Conference
Fluidigm to Present at the Bank of America Merrill Lynch 2014 Healthcare Conference   SOUTH SAN FRANCISCO, Calif. – May 6, 2014 – Fluidigm Corporation (NASDAQ:FLDM) today announced that Chief Financial Officer Vikram Jog and Vice President of Corporate Development Un Kwon-Casado will present at the
View HTML